Last updated Nov 3, 2026
A 10-year-old with congenital profound hearing loss begins to have difficulty seeing at night. Ophthalmologic exam reveals retinitis pigmentosa. He also has vestibular dysfunction.
AR; for types 1 and 2, genes whose proteins are thought to form one network (the "Usher interactome") in inner ear hair cells and retinal photoreceptors; biallelic loss-of-function variants.
- Type 1: MYO7A (60% to 70%), CDH23, USH1C, PCDH15, USH1G; most severe
- Type 2: USH2A (57% to 79%, most common), ADGRV1, WHRN; moderate
- Type 3: CLRN1; progressive
Types:
| Type | Hearing Loss | Vestibular | RP Onset |
|---|---|---|---|
| 1 | Profound congenital | Absent | Early adolescence |
| 2 | Moderate-severe congenital | Usually asymptomatic (loss on testing in 40% to 80% in a small study) | Late adolescence or early adulthood |
| 3 | Progressive | Variable | Variable |
The type 1 and type 2 proteins are thought to interact with one another and are expressed in the ear and eye during and after development, where they are needed for the structure and function of the cilia that detect sound and light. When any one of them is absent or nonfunctional, the inner ear and retina degenerate. Recessive inheritance points to loss of function.
- Type 1: myosin-VIIa (MYO7A), harmonin (USH1C), cadherin-23 (CDH23), protocadherin-15 (PCDH15), and USH1G. Variants disrupt cochlear and vestibular hair cell development and photoreceptor maintenance, so hearing loss is profound from birth and vestibular responses are absent.
- Type 2: usherin (USH2A), ADGRV1, and whirlin (WHRN) appear to work as a complex in cochlear hair cell stereocilia and the photoreceptor periciliary membrane. Variants disrupt cochlear hair cell development and photoreceptor maintenance.
Severity tracks residual function. Biallelic null variants give the full syndrome, while missense variants that leave partly working protein typically give hearing loss alone in type 1 genes or retinitis pigmentosa alone in USH2A. USH2A also carries deep intronic variants that standard exome sequencing does not detect, and large single- and multiexon variants.
- Sensorineural hearing loss
- Retinitis pigmentosa (progressive blindness)
- Vestibular dysfunction (type 1, variable in type 3)
- Leading cause of deaf-blindness
- Audiometry/ABR confirms sensorineural hearing loss; newborn hearing screen typically abnormal in types 1 and 2
- Ophthalmologic evaluation with electroretinogram (ERG) and dilated fundus exam to detect retinitis pigmentosa, often before symptoms
- Vestibular testing: areflexia supports type 1; vestibular function is typically normal in type 2
- Molecular confirmation: multigene panel (MYO7A, USH2A, CDH23, PCDH15, CLRN1, and others), with type correlating to gene and phenotype
- Hearing rehabilitation: hearing aids; early cochlear implantation is favored in profound type 1 loss
- Vision surveillance: serial ophthalmologic exams; low-vision services, UV protection, and vitamin A supplementation in selected cases per specialist guidance
- Vestibular/balance support and fall-prevention strategies in type 1
- Early communication-modality planning and deaf-blind support services as vision declines
"USHER": UnSteady (balance issues), HEaring loss, Retinitis pigmentosa. The three cardinal features are spelled out in the name.